bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
2.710
+0.500 (22.62%)
Apr 28, 2026, 2:44 PM EDT - Market open
bioAffinity Technologies Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for bioAffinity Technologies.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for bioAffinity Technologies.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 1, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $180 | Strong Buy | Initiates | $180 | +6,542.07% | Jul 23, 2024 |
Financial Forecast
Revenue This Year
7.45M
from 6.16M
Increased by 20.95%
Revenue Next Year
n/a
from 7.45M
EPS This Year
-8.26
from -8.66
EPS Next Year
n/a
from -8.26
Revenue Forecast
| Revenue | 2026 |
|---|---|
| High | 7.7M |
| Avg | 7.5M |
| Low | 7.2M |
Revenue Growth
| Revenue Growth | 2026 |
|---|---|
| High | 24.5% |
| Avg | 21.0% |
| Low | 16.2% |
EPS Forecast
| EPS | 2026 |
|---|---|
| High | -8.51 |
| Avg | -8.26 |
| Low | -7.94 |
EPS Growth
| EPS Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.